Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 1.1 | 0.4 | -2,559.9 | 0.0 |
| Revenue growth | 146.8% | -100.0% | | |
| Cost of goods sold | 3.9 | 1.9 | 660.9 | 0.3 |
| Gross profit | -2.8 | -1.5 | -3,220.8 | -0.3 |
| Gross margin | -255.1% | -333.6% | 125.8% | |
| Selling, general and administrative | | | 786.8 | |
| Research and development | 0.5 | 0.1 | 1,111.6 | |
| General and administrative | 3.7 | 1.7 | 181.7 | 0.1 |
| EBIT | -6.9 | -3.3 | -5,119.1 | 0.0 |
| EBIT margin | -636.6% | -758.6% | 200.0% | |
| Pre-tax income | -6.6 | -3.2 | -5.1 | -2.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -7.4 | -4.2 | -5.1 | -2.7 |
| Net margin | -678.0% | -945.4% | 0.2% | |
| |
| Diluted EPS | ($0.66) | ($0.53) | ($0.67) | ($0.32) |
| Shares outstanding (diluted) | 11.2 | 7.9 | 7.6 | 8.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|